Quinapril

Active ingredient description

Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Quinapril
C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA06

Medicines

Quinapril is the active ingredient of these drugs:

Drug
Countries

South Africa

Australia Canada South Africa United States

Italy

Austria Finland Germany Ireland Lithuania

Cyprus

Italy

Australia

France Tunisia

Spain

Poland

Spain

Spain

Poland

Australia

South Africa

South Africa

South Africa

Italy

South Africa

Quinapril is also found within below combination drugs:

ACCUPRO COMP , ACCURETIC , ACCUZIDE , ACEQUIDE , ACUILIX , BICETIL , LIDALTRIN DIU , QUINAPLUS , QUINAZIDE , QUINPREN PLUS

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Structured Product Labeling (SPL)
US
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

RJ84Y44811 - QUINAPRIL

CAS registry number

85441-61-8 - quinapril

90243-99-5 - Quinapril

SNOMED-CT

386874003 - Quinapril (substance)